Parkinson’s Disease

London, United Kingdom (Jan. 10, 2023) — Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol,…

With the end of the year approaching, we asked the Institute’s leadership for a sneak peek into what they are most excited for in the…

With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…